Improvement of photostability and dissolution profile of isradipine using inclusion complex

Journal of Pharmaceutical Investigation

Volumn 43, Issue 1, 2013, Pages 55-61

  Park, Jun Bom ^a   Lee, Gun Hee ^a   Kang, Ji Won ^a   Jeon, Ik Sung ^a   Kim, Jung Mi ^a   Kim, Ki Beom ^a   Kang, Chin Yang ^a  

^a Sahmyook University   (South Korea)

Author keywords

Inclusion complex; Isradipine; Photo stability; Sustained release; Cyclodextrin

Indexed keywords

BETA CYCLODEXTRIN; HYDROXYPROPYLMETHYLCELLULOSE; ISRADIPINE; LACTOSE; MAGNESIUM STEARATE; MICROCRYSTALLINE CELLULOSE;

ARTICLE; COMPLEX FORMATION; DRUG SOLUBILITY; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INCLUSION COMPLEX; INFRARED SPECTROSCOPY; IRRADIATION; PHOTODEGRADATION; PRIORITY JOURNAL; TABLET COMPRESSION;

EID: 84874790365     PISSN: 20935552     EISSN: 20936214     Source Type: Journal    
DOI: 10.1007/s40005-013-0052-9     Document Type: Article

References (28)

1. Alderman D (1984) A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms. Int J Pharm Tech Prod Mfr 5: 1-9.
2. Chen GL, Hao WH (1998) In vitro performance of floating sustained-release capsule of verapamil. Drug Dev Ind Pharm 24: 1067-1072.
3. Chrysant SG, Cohen M (1997) Long-term antihypertensive effects with chronic administration of isradipine controlled release. Curr Ther Res 58: 1-9.
4. Elghany MFA, Elzeany BE, Elkawy MA, Stewart JT (1996) A stability indicating high performance liquid chromatographic assay of isradipine in pharmaceutical preparations. Anal Lett 29: 1157-1165.
5. Fouad EA, El-Badry M, Alanazi FK, Arafah MM, Al-Ashban R, Alsarra IA (2010) Preparation and investigation of acetyl salicylic acid-caffeine complex for rectal administration. Pharm Dev Technol 15: 249-257.
6. Gao X, Nishimura K, Hirayama F, Arima H, Uekama K, Schmid G, Terao K, Nakata D, Fukumi H (2006) Enhanced dissolution and oral bioavailability of coenzyme Q10 in dogs obtained by inclusion complexation with γ-cyclodextrin. Asian J Pharm Sci 1: 95-102.
7. Hancock BC, Parks M (2000) What is the true solubility advantage for amorphous pharmaceuticals? Pharm Res 17: 397-404.
8. Hayashi T, Kanbe H, Okada M, Kawase I, Ikeda Y, Onuki Y, Kaneko T, Sonobe T (2007) In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets. Int J Pharm 341: 105-113.
9. Kapsi SG, Ayres JW (2001) Processing factors in development of solid solution formulation of itraconazole for enhancement of drug dissolution and bioavailability. Int J Pharm 229: 193-203.
10. Karavas E, Georgarakis E, Sigalas MP, Avgoustakis K, Bikiaris D (2007) Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions. Eur J Pharm Biopharm 66: 334-347.
11. Lee KR, Kim EJ, Seo SW, Choi HK (2008) Effect of poloxamer on the dissolution of felodipine and preparation of controlled release matrix tablets containing felodipine. Arch Pharm Res 31: 1023-1028.
12. Leroueil-Le Verger M, Fluckiger L, Kim YI, Hoffman M, Maincent P (1998) Preparation and characterization of nanoparticles containing an antihypertensive agent. Eur J Pharm Biopharm 46: 137-143.
13. Leuner C, Dressman J (2000) Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 50: 47-60.
14. Liu J, Zhang F, McGinity JW (2001) Properties of lipophilic matrix tablets containing phenylpropanolamine hydrochloride prepared by hot-melt extrusion. Eur J Pharm Biopharm 52: 181-190.
15. Loftsson T, Brewster ME (1996) Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci 85: 1017-1025.
16. Matsuda H, Arima H (1999) Cyclodextrins in transdermal and rectal delivery. Adv Drug Del Rev 36: 81-99.
17. Mazer N, Abisch E, Gfeller JC, Laplanche R, Bauerfeind P, Cucala M, Lukachich M, Blum A (1988) Intragastric behavior and absorption kinetics of a normal and "floating" modified-release capsule of isradipine under fasted and fed conditions. J Pharm Sci 77: 647-657.
18. Mielcarek J, Daczkowska E (1999) Photodegradation of inclusion complexes of isradipine with methyl-β-cyclodextrin. J Pharmcet Biomed Anal 21: 393-398.
19. Mummidi V, Jayanthi V (2012) Effect of hydrophilic polymers on isradipine complexation with hydroxypropyl β-cyclodextrin. Drug Dev Ind Pharm. doi: 10. 3109/03639045. 2012. 686508.
20. Pouton CW (2006) Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci 29: 278-287.
21. Salsa T, Veiga F, Pina M (1997) Oral controlled-release dosage forms. I. Cellulose ether polymers in hydrophilic matrices. Drug Dev Ind Pharm 23: 929-938.
22. Scalia S, Villani S, Casolari A (1999) Inclusion Complexation of the Sunscreen Agent 2-Ethylhexyl-p-dimethylaminobenzoate with Hydroxypropyl-β-cyclodextrin: Effect on Photostability. J Pharm Pharmacol 51: 1367-1374.
23. Tran TTD, Tran PHL, Choi HG, Han HK, Lee BJ (2010) The roles of acidifiers in solid dispersions and physical mixtures. Int J Pharm 384: 60-66.
24. Tran PHL, Tran TTD, Park JB, Lee BJ (2011) Controlled release systems containing solid dispersions: strategies and mechanisms. Pharm Res 28: 2353-2378.
25. Uekama K (2004) Design and evaluation of cyclodextrin-based drug formulation. Chem Pharm Bull (Tokyo) 52: 900-915.
26. Venkatesh DN, Karthick S, Umesh M, Valliappan R, Vivek G, Samanta M, Elango K (2009) Studies on the preparation and characterisation of β-cyclodextrin-aceclofenac inclusion complexes. Malay 7: 153-168.
27. Wang Z, Horikawa T, Hirayama F, Uekama K (1993) Design and in vitro evaluation of a modified release oral dosage form of nifedipine by hybridization of hydroxypropyl-β-cyclodextrin and hydroxypropylcellulose. J Pharm Pharmacol 45: 942-946.
28. Wong S, Kellaway I, Murdan S (2006) Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles. Int J Pharm 317: 61-68.